COVID COLLECTION:
__________________________
COVID THREAT FAKE:
Knut Wittkowsky PhD DS-MB:
__________________________
MORE LIVES LOST THAN SAVED FROM LOCKDOWNS:
__________________________
WHAT IT IS: FLU & EM INJURY:
__________________________
MOST WILL BE KILLED BY THE INJECTIONS:
Nobel Prize Winner: Mass COVID Vaccination an ‘Unacceptable Mistake’
July 21, 2021/by Life Site News
French virologist and Nobel Prize winner Luc Montagnier called mass vaccination against the coronavirus during the pandemic “unthinkable” and a historical blunder that is “creating the variants” and leading to deaths from the disease.
“It’s an enormous mistake, isn’t it? A scientific error as well as a medical error. It is an unacceptable mistake,” Montagnier said in an interview translated and published by the RAIR Foundation USA yesterday. “The history books will show that, because it is the vaccination that is creating the variants.”
Many epidemiologists know it and are “silent” about the problem known as “antibody-dependent enhancement,” Montagnier said.
“It is the antibodies produced by the virus that enable an infection to become stronger,” he said in an interview with Pierre Barnérias of Hold-Up Media earlier this month.
Nobel Prize winner: Mass COVID vaccination an ‘unacceptable mistake’
In every country, ‘the curve of vaccination is followed by the curve of deaths,’ the famous virologist said.
Wed May 19, 2021 – 6:59 pm EST
By Celeste McGovern
Note to readers, added May 27, 2021: While LifeSiteNews has only reported what Montagnier has said, other scientists have rejected, in the strongest terms, his thesis that vaccines are causing dangerous variants. Former Pfizer vice president Dr. Michael Yeadon has said, “There is no evidence at all that vaccination is leading or will lead to ‘dangerous variants,’” and that the notion of such deadly variants is “absurdly impossible … not [even] like an opinion difference,” but “just a lie” in order to justify unnecessary “top-up” (booster) vaccines. Others have also highlighted there is “no proof” for these theories, referring to them as “nonsense,” while likewise vehemently opposing the general distribution of these experimental gene-therapy COVID-19 vaccines and warning of serious damaging consequences. Such warnings remain credible due to the trend of spikes in deaths which may be due to a number of factors including antibody dependent enhancement, vaccine-associated illnesses, or other conditions.
Secondly, Montagnier did notsay that everyone who received experimental COVID-19 vaccines would “all die” within two years. This quote was falsely attributed to him in a fake news meme that has been widely distributed.
May 19, 2021 (LifeSiteNews) – French virologist and Nobel Prize winner Luc Montagnier called mass vaccination against the coronavirus during the pandemic “unthinkable” and a historical blunder that is “creating the variants” and leading to deaths from the disease.
“It’s an enormous mistake, isn’t it? A scientific error as well as a medical error. It is an unacceptable mistake,” Montagnier said in an interview translated and published by the RAIR Foundation USA yesterday. “The history books will show that, because it is the vaccination that is creating the variants.”
Many epidemiologists know it and are “silent” about the problem known as “antibody-dependent enhancement,” Montagnier said.
“It is the antibodies produced by the virus that enable an infection to become stronger,” he said in an interview with Pierre Barnérias of Hold-Up Media earlier this month.
Vaccination leading to variants
While variants of viruses can occur naturally, Montagnier said that vaccination is driving the process. “What does the virus do? Does it die or find another solution?”
“It is clear that the new variants are created by antibody-mediated selection due to the vaccination.”
Vaccinating during a pandemic is “unthinkable” and is causing deaths, the winner of the 2008 Nobel Prize in Medicine for discovery
“The new variants are a production and result from the vaccination. You see it in each country, it’s the same: in every country deaths follow vaccination,” he said.
A video published last week on YouTube uses data from the Institute for Health Metrics and Evaluation at the University of Washington to illustrate the spikes in deaths in numerous countries across the globe after the introduction of COVID vaccination, confirming Montagnier’s observation.
The French interviewer pointed to data from the World Health Organization (WHO) showing that since the vaccines were introduced in January, new infections contamination have “exploded,” along with deaths, “notably among young people.”
“Yes,” agreed Montagnier who is a professor at Shanghai Jiao Tong University. “With thrombosis, etc.”
Thrombosis – or blood clots — have been an unexpected problem linked to the new coronavirus vaccines and the cause of AstraZeneca’s vaccine being pulled in several countries. The head of Canada’s public health agency, Theresa Tam, told a press conference Tuesday that there are now 21 confirmed cases of vaccine-induced thrombotic thrombocytopenia, or VITT, including among three women who died from the blood-clotting disorder potentially linked to AstraZeneca’s vaccine and another 13 cases are under investigation.
Breakthrough cases
Montagnier said that he is currently conducting research with those who have become infected with the coronavirus after getting the vaccine. The Centers for Disease Control and Prevention reported in April that it had received 5,800 reports of people who had “breakthrough” COVID after being vaccinated, including 396 people who required hospitalization and 74 patients who died.
“I will show you that they are creating the variants that are resistant to the vaccine,” Montagnier said.
Coronavirus made in a lab
The famous French virologist created waves in April 2020 when he told a French television station that he believed SARS-CoV2, the new pandemic coronavirus, was man-made in a laboratory. The “presence of elements of HIV and germ of malaria in the genome of coronavirus is highly suspect and the characteristics of the virus could not have arisen naturally,” he said.
Though he was ridiculed by French experts for having “a conspiracy vision that does not relate to the real science,” Montagnier published a paper in July 2020 supporting his claims that the novel coronavirus must have originated from human experimentation in a lab – a theory that has recently resurfaced and is currently considered the most likely origin of the virus.
LifeSiteNews has produced an extensive COVID-19 vaccines resources page. View it here.
RELATED:
Frontline Doctors: Experimental vaccines are ‘not safer’ than COVID-19
Thousands of reports of menstrual irregularities, reproductive dysfunction following COVID vaccines
https://www.naturalnews.com/2021-07-13-doctor-says-mrna-vaccines-kill-most-people.html
__________________________
CORRUPT AGENTS:
FAUCI’S WIFE’S INVOLVEMENT
___________________________
MASKS:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072811/
Int J Environ Res Public Health. 2021 Apr; 18(8): 4344.
Published online 2021 Apr 20. doi: 10.3390/ijerph18084344
PMCID: PMC8072811
PMID: 33923935
Is a Mask That Covers the Mouth and Nose Free from Undesirable Side Effects in Everyday Use and Free of Potential Hazards?
Kai Kisielinski,1 Paul Giboni,2 Andreas Prescher,3 Bernd Klosterhalfen,4 David Graessel,5 Stefan Funken,6 Oliver Kempski,7 and Oliver Hirsch8,*
MASKS CONTAINING GRAPHENE:
Coronavirus masks containing graphene should not be sold, Canadian health authorities say: https://www.foxnews.com/health/coronavirus-masks-graphene-canada-warning
MASKS WILL DESTROY OCEANS:
___________________________
PCR TESTS:
____________________________
https://www.journalofinfection.com/article/S0163-4453(21)00265-6/fulltext#tbl0001
https://www.journalofinfection.com/article/S0163-4453(21)00265-6/fulltext
HALF OF CV HOSPITALIZATIONS: PTS + AFTER ADMISSION!!!
https://www.the-sun.com/news/3356548/half-covid-hospitalisations-patients-positive-after-admission/
My writing:
Let’s not call it a swab, because that’s not its true purpose.
It’s a PROBE that, with the instructed pressure and twisting which would have no purpose other than to inject substances:
1. carcinogenic ethylene oxide to break down the protective epithelial linings of the nasal sinuses,
2. microscopic metallic theragrippers to travel through the porous cribriform plate and grab onto brain tissue, and
3. nano hydrogel to travel through the cribriform plate and build upon the theragrippers first a 2D, then a 3D crystalline structure that becomes exogenously radio-accessible to function as a microwave antenna for control and other purposes.
This is not sci-fi. See DARPA Lawrence-Livermore neuroweaponry expert James Giordano PhD on utube.
____________________________
COMORBIDITIES:
https://www.cdc.gov/nchs/nvss/vsrr/covid_weekly/index.htm#Comorbidities
ONLY 5%!
____________________________
NEUROWEAPONRY:
_____________________________
LUCIFERASE:
https://www.brighteon.com/44b51c62-ea43-4923-b15e-26b4fc2db6c3
_____________________________
MICROWAVE RADIATION:
_____________________________
_____________________________
FAUX-VAX INJECTIONS:
Astra-Zeneca MSDS:
Pfizer MSDS:
____________________________
____________________________
Superparamagnetic nanoparticle delivery of DNA vaccine
Methods Mol Biol. 2014;1143:181-94.
doi: 10.1007/978-1-4939-0410-5_12.
Fatin Nawwab Al-Deen 1 , Cordelia Selomulya, Charles Ma, Ross L Coppel
No Vaxx Rebellion; Resist, Refuse, Reject
https://www.globalresearch.ca/no-vaxx-rebellion-resist-refuse-reject/5746766
https://pubmed.ncbi.nlm.nih.gov/24715289/
Affiliations
- PMID: 24715289
- DOI: 10.1007/978-1-4939-0410-5_12
Abstract
The efficiency of delivery of DNA vaccines is often relatively low compared to protein vaccines. The use of superparamagnetic iron oxide nanoparticles (SPIONs) to deliver genes via magnetofection shows promise in improving the efficiency of gene delivery both in vitro and in vivo. In particular, the duration for gene transfection especially for in vitro application can be significantly reduced by magnetofection compared to the time required to achieve high gene transfection with standard protocols. SPIONs that have been rendered stable in physiological conditions can be used as both therapeutic and diagnostic agents due to their unique magnetic characteristics. Valuable features of iron oxide nanoparticles in bioapplications include a tight control over their size distribution, magnetic properties of these particles, and the ability to carry particular biomolecules to specific targets. The internalization and half-life of the particles within the body depend upon the method of synthesis. Numerous synthesis methods have been used to produce magnetic nanoparticles for bioapplications with different sizes and surface charges. The most common method for synthesizing nanometer-sized magnetite Fe3O4 particles in solution is by chemical coprecipitation of iron salts. The coprecipitation method is an effective technique for preparing a stable aqueous dispersions of iron oxide nanoparticles. We describe the production of Fe3O4-based SPIONs with high magnetization values (70 emu/g) under 15 kOe of the applied magnetic field at room temperature, with 0.01 emu/g remanence via a coprecipitation method in the presence of trisodium citrate as a stabilizer. Naked SPIONs often lack sufficient stability, hydrophilicity, and the capacity to be functionalized. In order to overcome these limitations, polycationic polymer was anchored on the surface of freshly prepared SPIONs by a direct electrostatic attraction between the negatively charged SPIONs (due to the presence of carboxylic groups) and the positively charged polymer. Polyethylenimine was chosen to modify the surface of SPIONs to assist the delivery of plasmid DNA into mammalian cells due to the polymer’s extensive buffering capacity through the “proton sponge” effect.
Similar articles
Al-Deen FN, Ho J, Selomulya C, Ma C, Coppel R. Langmuir. 2011 Apr 5;27(7):3703-12. doi: 10.1021/la104479c. Epub 2011 Mar 1. PMID: 21361304
____________________________
SPIKE PROTEINS’ MECHANISMS:
Orthomolecular Medicine News Service, June 21, 2021
Resolving “Long-Haul COVID” and Vaccine Toxicity: Neutralizing the Spike Protein
Commentary by Thomas E. Levy, MD, JD
(OMNS June 21, 2021) Although the mainstream media outlets might have you believe otherwise, the vaccines that continue to be administered for the COVID pandemic are emerging as very substantial sources of morbidity and mortality themselves. While the degree to which these negative outcomes of the COVID vaccines can be debated, there is no question that enough disease and death have already occurred to warrant cessation of the administration of these vaccines until additional, completely scientifically-based research can examine the balance between its now clear-cut side effects versus its potential (and still not yet clearly proven) ability to prevent new COVID infections.
Nevertheless, enough vaccinations have already been administered to warrant concern that a new “pandemic” of illness and death may well be emerging from the side effects that continue to be documented in steadily increasing numbers. The vaccine-induced “culprit” that is now receiving most of the attention and is the focus of much new research is the COVID virus fragment known as the spike protein. Its physiological impact appears to be doing far more harm than good (COVID antibody induction), and its manner of introduction appears to be fueling its ongoing replication with a continuing presence inside the body for an indefinite length of time.
The physical appearance of the COVID virus can been depicted as a central sphere of viral protein surrounded completely by spear-like appendages. Known as spike proteins, they are very analogous to the quills surrounding a porcupine. And just as the porcupine stabs its victim, these spike proteins penetrate into cell membranes throughout the body. After this penetration, protein-dissolving enzymes are activated, the cell membrane breaks down, the viral sphere enters the cytoplasm through this membrane breach, and the metabolism of the cell is subsequently “hijacked” to manufacture more viral particles. These spike proteins are the focus of a great deal of ongoing research examining vaccine side effects (Belouzard et al., 2012; Shang et al., 2020).
The spike protein first attaches to ACE2 (angiotensin converting enzyme 2) receptors in the cell membranes (Pillay, 2020). This initial binding step is vital to triggering the subsequent sequence of events that brings the virus inside the cell. When this binding is blocked by competition or prompt enough displacement with an appropriate therapeutic agent, the virus cannot enter the cell, the infectious process is effectively stopped, and the immune defenses of the body are freed to mop up, metabolize, and eliminate the viral pathogens, or just the spike protein alone if free and no longer attached to a viral particle.
Although ACE2 is found in many different cells throughout the body, it is especially noteworthy to realize that it is the initial target bound by coronavirus on the epithelial cells lining the airways after pathogen inhalation (Hoffmann et al., 2020). ACE2 expression (concentration) is also especially high on lung alveolar epithelial cells (Alifano et al., 2020). This cell membrane-bound virus can then begin the process that eventually results in the severe acute respiratory syndrome (SARS) seen in clinically-advanced COVID infections (Perrotta et al., 2020; Saponaro et al., 2020). The SARS presentation manifests most clearly when the degree of oxidative stress in the lungs is very elevated. This stage of COVID infection-related extreme oxidative stress is often referred to in the literature as a cytokine storm, and left unchecked this invariably leads to death (Hu et al., 2021).
Increasing concern has focused on the continued presence of the spike protein in the blood by itself, unattached to a virion, following COVID vaccination. Supposedly intended to initiate an immune response to the entire virus particle, the spike protein injections are disseminating throughout the body rather than staying put in the upper arm at the vaccine site while the immune response to it evolves. Furthermore, it also appears that these circulating spike proteins can enter cells on their own and replicate themselves without attached virus particles. This not only wreaks havoc inside those cells, it helps to assure the indefinite presence of the spike protein throughout the body.
It has also been suggested that large amounts of spike protein are just binding ACE2 receptors and not proceeding any further into the cell, effectively blocking or disabling normal ACE2 function in a given tissue. Additionally, when the spike protein binds a cell wall and “stops” there, the spike protein serves as a hapten (antigen) which can then initiate an autoimmune (antibody or antibody-like) response to the cell itself, rather than to the virus particle to which it is usually attached. Depending on the cell types to which such spike proteins bind, a wide variety of diseases with autoimmune qualities can result.
Finally, another very worrisome property of the spike protein which alone would be of great concern is that the spike protein itself appears to be highly toxic. This intrinsic toxicity, along with the apparent ability of the spike protein to replicate itself indefinitely within the cells it enters, probably represents the way in which the vaccine can inflict its worst long-term damage, as the production of this toxin can continue indefinitely without other external factors at play.
In fact, the long-haul COVID syndrome likely represents a low-grade unresolved smoldering COVID infection with the same kind of spike protein persistence and clinical impact as is seen in many individuals after their COVID vaccinations (Mendelson et al., 2020; Aucott and Rebman, 2021; Raveendran, 2021).
While the totality of the mechanisms involved are far from being completely understood and worked out, the increasing occurrence of post-vaccine clinical complications is nevertheless very clear-cut and must be addressed as rapidly and effectively as possible. By itself, the disruption of ACE2 receptor function in so many areas of the body has resulted in an array of different side effects (Ashraf et al., 2021). Such clinical complications being seen in different organ systems and areas of the body, can all occur in the following three clinical situations. All three are “spike protein syndromes,” although the acute infection always includes the entirety of the virus particles along with the spike protein during the initial phases of the infection.
- in an active COVID-19 infection,
- during the long-haul COVID syndrome, or
- in response to a spike protein-laden vaccine, include the following:
- Heart failure, heart injury, heart attack, myocarditis (Chen et al., 2020; Sawalha et al., 2021)
- Pulmonary hypertension, pulmonary thromboembolism and thrombosis, lung tissue damage, possible pulmonary fibrosis (McDonald, 2020; Mishra et al., 2020; Pasqualetto et al., 2020; Potus et al., 2020; Dhawan et al., 2021)
- Increased venous and arterial thromboembolic events (Ali and Spinler, 2021)
- Diabetes (Yang et al., 2010; Lima-Martinez et al., 2021)
- Neurological complications, including encephalopathy, seizures, headaches, and neuromuscular diseases. Also, hypercoagulability and stroke (AboTaleb, 2020; Bobker and Robbins, 2020; Hassett et al., 2020; Hess et al., 2020)
- Gut dysbiosis, inflammatory bowel disease, and leaky gut (Perisetti et al., 2020; Zeppa et al., 2020; Hunt et al., 2021)
- Kidney damage (Han and Ye, 2021)
- Impaired male reproductive capacity (Seymen, 2021)
- Skin lesions and other cutaneous manifestations (Galli et al., 2020)
- General autoimmune diseases, autoimmune hemolytic anemia (Jacobs and Eichbaum, 2021; Liu et al., 2021)
- Liver injury (Roth et al., 2021)
In structuring a clinical protocol to stop the ravages of persistent spike protein presence throughout the body, it is first important to realize that the protocol should be able to effectively treat any aspect of COVID infection, including those periods during active infection, after “active” infection (long-haul COVID), and during ongoing spike protein presence secondary to either “chronic” COVID infection or resulting from COVID vaccine administration.
As is the case with any treatment for any condition, factors of expense, availability, and patient compliance always play a role in determining what treatment a given patient will actually undergo for a given period of time. As such, no one specific protocol will be appropriate for all patients, even if the same pathology is present. Ideally, of course, the best protocol is to use all of the options discussed below. When the entirety of the protocol is not possible or feasible, which is most often the case, the combination of HP nebulization, high-dose vitamin C, and appropriately-dosed ivermectin is an excellent way to effectively address long-haul COVID and persistent spike protein syndromes.
Much of the rationale of the protocols is based on what is known about the spike protein and how it appears to inflict its harm. The following aspects of spike protein pathophysiology need to all be considered in crafting an optimal treatment protocol:
- The ongoing production of spike protein by the vaccine-supplied mRNA into the cells for the purpose of stimulating the production of neutralizing antibodies (Khehra et al., 2021)
- The binding of the spike protein, with or without an attached virion, to an ACE2 binding site on the cell wall, as an initial step to dissolving that portion of the cell wall, permitting the spike protein (and attached virus particle if present) into the cell
- The binding of the spike protein to an ACE2 binding site, but just remaining bound to that site and not initiating enzymatic degradation of the cell wall, with or without an attached virion
- The degree to which circulating spike protein is present in the blood and actively disseminating throughout the body
- The fact that the spike protein by itself is toxic (pro-oxidant in nature) and capable of generating disease-generating oxidative stress throughout the body. This is addressed most directly by persistent and highly-dosed vitamin C.
Therapeutic Agents and Their Mechanisms
A substantial number of agents have already been found to be highly effective in resolving COVID infections, and even more are continuing to be discovered as worldwide research efforts have so intensely focused on curing this infection (Levy, 2020). Some of the most effective agents and their mechanisms of actions include the following:
- Hydrogen peroxide (HP) nebulization. Correctly applied, this treatment eliminates acute COVID pathogen presence and any other chronic pathogen colonizations persisting in the aerodigestive tract. Also, a positive healing effect on the lower digestive tract is typically seen, as less pathogens and their associated pro-oxidant toxins are chronically swallowed. Stunning anecdotal evidence has already been seen documenting the ability of HP nebulization to cure even advanced COVID infections (20 of 20 cases) as a monotherapy. (Levy, 2021). All of the supporting research, scientific analysis, and practical suggestions on this therapy is available as a free eBook download [Rapid Virus Recovery] (Levy, 2021).
- Vitamin C. Vitamin C works synergistically with HP in eradicating pathogens. It gives strong general immune support, while working to support the optimal healing of damaged cells and tissues. Clinically, it is the most potent antitoxin ever described in the literature, and no reports of it failing to neutralize any acute intoxication when administered appropriately have been published. Continuing persistent and highly-dosed vitamin C in all its forms will prove to be the most useful intervention when there is a large amount of circulating toxic spike protein present. Intravenous, regular oral forms, and liposome-encapsulated oral forms are all very useful in resolving any infection and neutralizing any toxin (Levy, 2002). There is also a polyphenol-based supplement that appears to allow some humans to synthesize their own vitamin C, which could prove to be of enormous protective and healing capacity with COVID patients and vaccine recipients. (https://formula216.com/).
- Ivermectin. This agent has powerful antiparasitic and antiviral properties. Evidence indicates that ivermectin binds the ACE2 receptor site that the spike protein needs to bind to proceed with entry into the cell and the replication of viral protein (Lehrer and Rheinstein, 2020; Eweas et al., 2021). Also, under some circumstances, the binding of the spike protein to the ACE2 receptor does not activate the enzymes needed to enter the cell. Possibly, ivermectin might also competitively displace such bound spike protein from the cell walls as well when a sufficient dose is taken. It also appears that circulating spike protein can be bound up directly by ivermectin, rendering it inactive and making it accessible for metabolic processing and excretion (Saha and Raihan, 2021). Where there has been mass administration of ivermectin for parasitic diseases in Africa there has also been noted a significantly lower incidence of COVID-19 infection (Hellwig and Maia, 2021). Ivermectin is also very safe when administered appropriately (Munoz et al., 2018).
- Hydroxychloroquine (HCQ) and Chloroquine (CQ). Both HCQ and CQ have been shown to be very effective agents in resolving acute COVID-19 infections. They have also both been shown to be zinc ionophores that can increase intracellular zinc levels which can then inhibit the enzyme activity needed for viral replication. However, both HCQ and CQ have also been found to block the binding of COVID virus spike proteins to the ACE2 receptors needed to initiate viral entry into the cells, giving scientific support for their utility as more directly interfering with spike protein activity before the virus ever breaches the cell (Fantini et al., 2020; Sehailia and Chemat, 2020; Wang et al., 2020).
- Quercetin. Similar to HCQ and CQ, quercetin also serves as a zinc ionophore. And like HCQ and CQ, quercetin appears to also work to block the binding of COVID virus spike proteins to the ACE2 receptors, impairing spike protein-virus entry into the cell, or impairing spike protein alonef from entering the cells (Pan et al., 2020; Derosa et al., 2021). Many other phytochemicals and bioflavonoids are demonstrating this ACE2 binding capacity as well (Pandey et al., 2020; Maiti and Banerjee, 2021).
- Other Bio-Oxidative Therapies. These include ozone, ultraviolet blood irradiation, and hyperbaric oxygen therapy (in addition to hydrogen peroxide and vitamin C). These three therapies are highly effective in patients with acute COVID infections. It is less clear how effective they would be for long-haul COVID syndrome and patients suffering from ongoing vaccine-generated spike protein syndromes. That is not to say, however, that all three would not prove to be just as excellent for dealing with the spike protein as with the intact virus. It just remains to be determined.
- Baseline Vital Immune Support Supplementation. There are definitely hundreds, and perhaps thousands, of quality vitamin, mineral, and nutrient supplements that are all capable of making some contribution to reaching and maintaining optimal health, while minimizing the chances of contracting any kind of infectious disease. A baseline regimen of supplementation that factors in expense, overall health impact, and convenience should include vitamin C, vitamin D3, magnesium chloride (other forms good, but chloride form optimal for antiviral impact), vitamin K2, zinc, and an iodine supplement, such as Lugol’s solution or iodoral. More specific guidance in dosing can be found in Appendix A of Hidden Epidemic, also available as a free eBook download (Levy, 2017). Specifics on mixing up a solution of magnesium chloride for regular supplementation are also available (Levy, 2020).
[More detail on the therapeutic agents above is available in Chapter 10 of Rapid Virus Recovery]
The suggested optimal way to deal with acute COVID that has evolved into long-haul COVID, or with symptoms consistent with the toxic effects of circulating spike protein post-vaccination, is to always eliminate any active or chronic areas of pathogen proliferation with HP nebulization. Vitamin C supplementation should be optimized at the same time. 50-gram infusions of sodium ascorbate should be administered at least several times weekly as long as there is symptomatology attributable to long-haul COVID and circulating spike protein. Initially, a 25-gram infusion of sodium ascorbate given three times a day should prove to be even more effective as circulating vitamin C is rapidly excreted. Oral vitamin C supplementation should be taken as well, either as several grams of liposome-encapsulated vitamin C daily, or as a teaspoon of sodium ascorbate powder several times daily. One capsule daily of Formula 216 can be added to this as well.
With the “foundation” of HP nebulization and vitamin C supplementation in place, the best prescription medicines to counter long-haul COVID and circulating spike protein would be with ivermectin first, and then HCQ or HQ if the clinical response is not acceptable. Dosages would need to be determined by the prescribing physician.
Along with the baseline immune support supplements noted above, quercetin, 500 to 1,000 mg daily, should be added as well.
Any and all of the above recommendations should be undertaken with the guidance of a trusted physician or other appropriately-trained health care professional.
Recap
Even as the COVID pandemic appears to be slowly subsiding, many individuals are now chronically ill with long-haul COVID and/or with the side effects of a COVID vaccination. It would appear that both clinical situations are primarily characterized by persistent presence of the spike protein and its negative impact on different tissues and organs.
Treatment is aimed at neutralizing the direct toxic impact of spike protein, while working to block its ability to bind the receptors needed to hijack the metabolism of the cell into making new viruses and/or more spike protein. At the same time, treatment measures are taken to assure that there is as complete an elimination of active or smoldering COVID infection remaining in the patient.
The views expressed in this article are the author’s and not necessarily those of the Orthomolecular Medicine News Service or all members of its Editorial Board. OMNS invites alternative viewpoints. Submissions may be sent directly to Andrew W. Saul, Editor, at the email contact address further below.
References
AboTaleb H (2020) Neurological complications in COVID-19 patients and its implications for associated mortality. Current Neurovascular Research 17:522-530. PMID: 32718292
Ali M, Spinler S (2021) COVID-19 and thrombosis: from bench to bedside. Trends in Cardiovascular Medicine
Alifano M, Alifano P, Forgez P, Iannelli A (2020) Renin-angiotensin system at the heart of COVID-19 pandemic. Biochemie 174:30-33. PMID: 32305506
Asraf U, Abokor A, Edwards J et al. (2021) SARS-CoV-2, ACE2 expression, and systemic organ invasion. Physiological Genomics 53:51-60. PMID: 33275540
Aucott J, Rebman A (2021) Long-haul COVID: heed the lessons from other infection-triggered illnesses. Lancet 397:967-968. PMID: 33684352
Belouzard S, Millet J, Licitra B, Whittaker G (2012) Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4:1011-1033. PMID: 22816037
Bobker S, Robbins M (2020) COVID-19 and headache: a primer for trainees. Headache 60:1806-1811. PMID: 32521039
Chen L, Li X, Chen M et al. (2020) The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovascular Research 116:1097-1100. PMID: 32227090
Derosa G, Maffioli P, D’Angelo A, Di Pierro F (2021) A role for quercetin in coronavirus disease 2019 (COVID-19). Phytotherapy Research 35:1230-1236. PMID: 33034398
Dhawan R, Gopalan D, Howard L et al. (2021) Beyond the clot: perfusion imaging of the pulmonary vasculature after COVID-19. The Lancet. Respiratory Medicine 9:107-116. PMID: 33217366
Eweas A, Alhossary A, Abdel-Moneim A (2021) Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2. Frontiers in Microbiology 11:592908. PMID: 33746908
Fantini J, Di Scala C, Chahinian H, Yahi N (2020) Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. International Journal of Antimicrobial Agents 55:105960. PMID: 32251731
Galli E, Cipriani F, Ricci G, Maiello N (2020) Cutaneous manifestation during COVID-19 pandemic. Pediatric Allergy and Immunology 31 Suppl 26:89-91. PMID: 33236439
Han x, Y Q (2021) Kidney involvement in COVID-19 and its treatments. Journal of Medical Virology 93:1387-1395. PMID: 33150973
Hassett C, Gedansky A, Migdady I et al. (2020) Neurologic complications of COVID-19. Cleveland Clinic Journal of Medicine 87:729-734. PMID: 32847818
Hellwig M, Maia A (2021) A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin. International Journal of Antimicrobial Agents 57:106248. PMID: 33259913
Hess D, Eldahshan W, Rutkowski E (2020) COVID-19-related stroke. Translational Stroke Research 11:322-325. PMID: 32378030
Hoffmann M, Kleine-Weber H, Schroeder S et al. (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271-280. PMID: 32142651
Hu B, Huang S, Yin L (2021) The cytokine storm and COVID-19. Journal of Medical Virology 93:250-256. PMID: 32592501
Hunt R, East J, Lanas A et al. (2021) COVID-19 and gastrointestinal disease: implications for the gastroenterologist. Digestive Diseases 39:119-139. PMID: 33040064
Jacobs J, Eichbaum Q (2021) COVID-19 associated with severe autoimmune hemolytic anemia. Transfusion 61:635-640. PMID: 33274459
Khehra N, Padda I, Jaferi U et al. (2021) Tozinameran (BNT162b2) vaccine: the journey from preclinical research to clinical trials and authorization. AAPS PharmSciTech 22:172. PMID: 34100150
Lehrer S, Rheinstein P (2020) Ivermectin docks to the SARS-CoV-2 spike receptor-binding domain attached to ACE2. In Vivo 34:3023-3026. PMID: 32871846
Levy T (2002) Curing the Incurable. Vitamin C, Infectious Diseases, and Toxins. Henderson, NV: MedFox Publishing
Levy T (2017) Hidden Epidemic: Silent oral infections cause most heart attacks and breast cancers. Henderson, NV: MedFox Publishing. Free eBook download available at https://hep21.medfoxpub.com/
Levy T (2020) Vaccinations, Vitamin C, Politics, and the Law. Orthomolecular Medicine News Service, January 20, 2020. http://orthomolecular.org/resources/omns/v16n05.shtml
Levy T (2020) COVID-19: How can I cure thee? Let me count the ways. Orthomolecular Medicine News Service, July 18, 2020. http://orthomolecular.org/resources/omns/index.shtml
Levy T (2021) Rapid Virus Recovery: No need to live in fear! Henderson, NV: MedFox Publishing. Free eBook download available at https://rvr.medfoxpub.com/
Levy T (2021) Hydrogen peroxide nebulization and COVID resolution. Orthomolecular Medicine News Service, May 10, 2021. http://orthomolecular.org/resources/omns/index.shtml
Lima-Martinez M, Boada C, Madera-Silva M et al. (2021) COVID-19 and diabetes: a bidirectional relationship. Clinica e Investigacion en Arteriosclerosis 33:151-157. PMID: 33303218
Liu Y, Sawalha A, Lu Q (2021) COVID-19 and autoimmune diseases. Current Opinion in Rheumatology 33:155-162. PMID: 33332890
Maiti S, Banerjee A (2021) Epigallocatechin gallate and theaflavin gallate interaction in SARS-CoV-2 spike-protein central channel with reference to the hydroxychloroquine interaction: bioinformatics and molecular docking study. Drug Development Research 82:86-96. PMID: 32770567
McDonald L (2021) Healing after COVID-19: are survivors at risk for pulmonary fibrosis? American Journal of Physiology. Lung Cellular and Molecular Physiology 320:L257-L265. PMID: 33355522
Mendelson M, Nel J, Blumberg L et al. (2020) Long-COVID: an evolving problem with an extensive impact. South African Medical Journal 111:10-12. PMID: 33403997
Mishra A, Lal A, Sahu K et al. (2020) An update on pulmonary hypertension in coronavirus disease-19 (COVID-19). Acta Bio-Medica 91:e2020155. PMID: 33525228
Munoz J, Ballester M, Antonijoan R et al. (2018) Safety and pharmacokinetic profile of fixed-dose ivermectin with an innovative 18 mg tablet in healthy adult volunteers. PLoS Neglected Tropical Diseases 12:e0006020. PMID: 29346388
Pan B, Fang S, Zhang J et al. (2020) Chinese herbal compounds against SARS-CoV-2: puerarin and quercetin impair the binding of viral S-protein to ACE2 receptor. Computational and Structural Biotechnology Journal 18:3518-3527. PMID: 33200026
Pandey P, Rane J, Chatterjee A et al. (2020) Targeting SARS-CoV-2 spike protein of COVID-19 with naturally occurring phytochemicals: an in silico study for drug development. Journal of Biomolecular Structure & Dynamics Jul 22. Online ahead of print. PMID: 32698689
Perisetti A, Gajendran M, Mann R et al. (2020) COVID-19 extrapulmonary illness-special gastrointestinal and hepatic considerations. Disease-A-Month 66:101064. PMID: 32807535
Pasqualetto M, Sorbo M, Vitiello M et al. (2020) Pulmonary hypertension in COVID-19 pneumoniae: It is not always as it seems. European Journal of Case Reports in Internal Medicine 7:002160. PMID: 33457379
Perrotta F, Matera M, Cazzola M, Bianco A (2020) Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? Respiratory Medicine 168:105996. PMID: 32364961
Pillay T (2020) Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein. Journal of Clinical Pathology 73:366-369. PMID: 32376714
Potus F, Mai V, Lebret M et al. (2020) Novel insights on the pulmonary vascular consequences of COVID-19. American Journal of Physiology. Lung Cellular and Molecular Physiology 319:L277-L288. PMID: 32551862
Raveendran A (2021) Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 15:145-146. PMID: 33341598
Roth N, Kim A, Vitkovski T et al. (2021) Post-COVID-19 cholangiopathy: a novel entity. The American Journal of Gastroenterology 116:1077-1082. PMID: 33464757
Saha J, Raihan M (2021) The binding mechanism of ivermectin and levosalbutamol with spike protein of SARS-CoV-2. Structural Chemistry Apr 12. Online ahead of print. PMID: 33867777
Saponaro F, Rutigliano G, Sestito S et al. (2020) ACE2 in the era of SARS-CoV-2: controversies and novel perspectives. Frontiers in Molecular Biosciences 7:588618. PMID: 33195436
Sawalha K, Abozenah M, Kadado A et al. (2021) Systematic review of COVID-19 related myocarditis: insights on management and outcome. Cardiovascular Revascularization Medicine: Including Molecular Interventions 23:107-113. PMID: 32847728
Sehailia M, Chemat S (2020) Antimalarial-agent artemisinin and derivatives portray more potent binding to Lys353 and Lys31-binding hostpots of SARS-CoV-2 spike protein than hydroxychloroquine: potential repurposing of artenimol for COVID-19. Journal of Biomolecular Structure & Dynamics Jul 22. Online ahead of print. PMID: 32696720
Seymen C (2021) The other side of COVID-19 pandemic: effects on male fertility. Journal of Medical Virology 93:1396-1402. PMID: 33200417
Shang J, Wan Y, Luo C et al. (2020) Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 117:11727-11734. PMID: 32376634
Wang N, Han S, Liu R et al. (2020) Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV spike pseudotyped virus. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology 79:153333. PMID: 32920291
Yang J, Lin S, Ji X, Guo L (2010) Binding of SARA coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetologica 47:193-199. PMID: 19333547
Zeppa S, Agostini D, Piccoli G et al. (2020) Gut microbiota status in COVID-19: an unrecognized player? Frontiers in Cellular and Infection Microbiology 10:576551 PMID: 33324572
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to fight illness. For more information: http://www.orthomolecular.org
Find a Doctor
To locate an orthomolecular physician near you: http://orthomolecular.org/resources/omns/v06n09.shtml
The peer-reviewed Orthomolecular Medicine News Service is a non-profit and non-commercial informational resource.
Editorial Review Board:
Albert G. B. Amoa, MB.Ch.B, Ph.D. (Ghana)
Seth Ayettey, M.B., Ch.B., Ph.D. (Ghana)
Ilyès Baghli, M.D. (Algeria)
Ian Brighthope, MBBS, FACNEM (Australia)
Gilbert Henri Crussol, D.M.D. (Spain)
Carolyn Dean, M.D., N.D. (USA)
Ian Dettman, Ph.D. (Australia)
Damien Downing, M.B.B.S., M.R.S.B. (United Kingdom)
Susan R. Downs, M.D., M.P.H. (USA)
Ron Ehrlich, B.D.S. (Australia)
Hugo Galindo, M.D. (Colombia)
Martin P. Gallagher, M.D., D.C. (USA)
Michael J. Gonzalez, N.M.D., D.Sc., Ph.D. (Puerto Rico)
William B. Grant, Ph.D. (USA)
Claus Hancke, MD, FACAM (Denmark)
Tonya S. Heyman, M.D. (USA)
Suzanne Humphries, M.D. (USA)
Ron Hunninghake, M.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Felix I. D. Konotey-Ahulu, MD, FRCP, DTMH (Ghana)
Jeffrey J. Kotulski, D.O. (USA)
Peter H. Lauda, M.D. (Austria)
Thomas Levy, M.D., J.D. (USA)
Alan Lien, Ph.D. (Taiwan)
Homer Lim, M.D. (Philippines)
Stuart Lindsey, Pharm.D. (USA)
Victor A. Marcial-Vega, M.D. (Puerto Rico)
Charles C. Mary, Jr., M.D. (USA)
Mignonne Mary, M.D. (USA)
Jun Matsuyama, M.D., Ph.D. (Japan)
Joseph Mercola, D.O. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Karin Munsterhjelm-Ahumada, M.D. (Finland)
Tahar Naili, M.D. (Algeria)
W. Todd Penberthy, Ph.D. (USA)
Zhiyong Peng, M.D. (China)
Isabella Akyinbah Quakyi, Ph.D. (Ghana)
Selvam Rengasamy, MBBS, FRCOG (Malaysia)
Jeffrey A. Ruterbusch, D.O. (USA)
Gert E. Schuitemaker, Ph.D. (Netherlands)
T.E. Gabriel Stewart, M.B.B.CH. (Ireland)
Thomas L. Taxman, M.D. (USA)
Jagan Nathan Vamanan, M.D. (India)
Garry Vickar, M.D. (USA)
Ken Walker, M.D. (Canada)
Raymond Yuen, MBBS, MMed (Singapore)
Anne Zauderer, D.C. (USA)
Andrew W. Saul, Ph.D. (USA), Editor-In-Chief
Associate Editor: Robert G. Smith, Ph.D. (USA)
Editor, Japanese Edition: Atsuo Yanagisawa, M.D., Ph.D. (Japan)
Editor, Chinese Edition: Richard Cheng, M.D., Ph.D. (USA)
Editor, French Edition: Vladimir Arianoff, M.D. (Belgium)
Editor, Norwegian Edition: Dag Viljen Poleszynski, Ph.D. (Norway)
Editor, Arabic Edition: Moustafa Kamel, R.Ph, P.G.C.M (Egypt)
Editor, Korean Edition: Hyoungjoo Shin, M.D. (South Korea)
Assistant Editor: Helen Saul Case, M.S. (USA)
Technology Editor: Michael S. Stewart, B.Sc.C.S. (USA)
Legal Consultant: Jason M. Saul, JD (USA)
Comments and media contact: drsaul@doctoryourself.com OMNS welcomes but is unable to respond to individual reader emails. Reader comments become the property of OMNS and may or may not be used for publication.
____________________________
MAGNETOFECTION:
Magnetofection: https://forlifeonearth.weebly.com/magnetofection.html
Medical Definition of SPIONS:
Superparamagnetic iron oxide nanoparticles (SPIONs) are a
type of MNP that show magnetic properties in the presence of
an external magnetic field.
HTTPS://WWW.SCIENCEDIRECT.COM/TOPICS/MEDICINE-AND-DENTISTRY/SUPERPARAMAGNETIC-IRON-OXIDE-NANOPARTICLE
IT IS TRUE:
“SPIONS” IN MODERNA MRNA VACCINE ARE MAKING PEOPLE PARAMAGNETIC
____________________________
GRAPHENE:
Big Pharma Injecting Graphene Oxide As Adjuvant In COVID Jabs!: https://principia-scientific.com/big-pharma-injecting-graphene-oxide-as-adjuvant-in-covid-jabs/
Coronavirus masks containing graphene should not be sold, Canadian health authorities say: https://www.foxnews.com/health/coronavirus-masks-graphene-canada-warning
Warnings Over Masks That Contain Graphene: https://www.euroweeklynews.com/2021/04/16/warnings-over-masks-that-contain-graphene/
Graphene Oxide Detection in Aqueous Suspension
Observational study in Optical and Electron Microscopy
https://www.globalresearch.ca/graphene-oxide-detection-aqueous-suspension/5749529
CITING
GRAPHENE OXIDE DETECTION IN AQUEOUS SUSPENSIONOBSERVATIONAL STUDY IN OPTICAL AND ELECTRON MICROSCOPY
_______
Crime Scene Vaccine: Nano Graphene Oxide in High Amounts Now Found in Moderna, Other Vaccines, also Sanofi Flu Vaccine, & Saline Solution Point to COVID-19 (& All Professed Variants) Being Graphene & 4G/5G Poisoning, Not a Virus
Posted on July 24, 2021 by Ramola D | 3 Comments
Report | Ramola D | July 24, 2021
In absolutely earthshaking news this week, Nano Graphene Oxide in high amounts has now been found also in the Moderna vaccine, in a Sanofi-Pasteur flu vaccine named Vaxigrip Tetra, in “all vaccines,” and now in Saline solution by different teams of Spanish and Argentinian researchers, as reported newly by La Quinta Columna and Orwell City, as well as by the group Info Vacunas.
These new findings–which confirm the recent findings by University of Almeria and La Quinta Columna researchers via electron and optical microscopy of Graphene Oxide in the Pfizer and Astrazeneca vaccines–are also bolstered by the earlier, published findings of Italian researchers Dr. Gatti and Dr. Stefano Montenari whose labs were raided by police shortly after they published their findings of metals and nanoparticles in all vaccines in 2018.
____________________________
Disodium Edetate Dihydrate:
https://pubchem.ncbi.nlm.nih.gov/compound/Disodium-edetate-dihydrate
____________________________
GERM THEORY:
Excerpt from “End of the Road for the Germ Theory” by Fergus Frank, 9.5.21: https://forlifeonearth.weebly.com/end-of-the-road-for-the-germ-theory.html
In the late 1920s, Royal Raymond Rife invented a microscope called the Rife Universal Microscope, with which he was not only able to see microzymas, but was also able to observe the life cycles of microorganisms:
A major upshot of Rife’s work was his ability, through several pleomorphic stages, to transform a virus he found in cancer tissue into a fungus, plant the fungus in an asparagus-based medium, and produce a bacillus E. coli, the type of microform indigenous to the human intestine. This was repeated hundreds of times. By this accomplishment, Rife showed that the pleomorphic capacity of microforms goes beyond the bacterial level to the fungal level. Dr. Young* has observed this cycle, and is suggesting that its progression to the last stage – mold – is critical. And he includes in this cycle the very important stages intermediate to microzymas and bacteria, the protein complexes usually referred to as viruses, and their immediate descendants, the cell-wall deficient forms detailed by Lida Mattman, Ph.D. * R. O. Young, S. R. Young (2010) The pH Miracle. Hachette Publishing, New York, USA.
____________________________
PRODUCING ELECTRICITY FROM LIVING BEINGS:
Mushrooms, bacteria and graphene to produce electricity
Setas, bacterias y grafeno para producir electricidad
They create a symbiosis of fungi and bacteria capable of producing electricity and conducting it with graphene.
The world of graphene is a Lewis Carroll universe. This supermaterial of the future lives in wonderland for now, as its industrial implementation is expensive and complex. But the laboratories continue to give birth to thousands of applications. In this case, literally: a bionic fungus to produce electricity.
In the quest to replace fossil fuels, science is always looking for alternative sources of energy that do not harm the environment. But who could have imagined a mushroom that produces electricity? Thanks to electricity-producing bacteria, researchers at the Stevens Institute of Technology (US) have created a symbiosis of mushrooms, which serve as a home for cyanobacteria printed on a 3D network of graphene ribbons, which collect their electricity.
3D printed bacteria and graphene
The cyanobacteria are able to release electrons during photosynthesis, while the fungus provides them with food and moisture to generate their bioelectricity.
A wider mushroom network could light up an LED bulb.
To realise their bionic mushroom, the researchers 3D printed an electronic ink containing graphene nano-ribbons on the cap of the living mushroom in a branching pattern. They then printed a biological ink containing cyanobacteria on the cap in a spiral pattern, which intersected with the e-ink at multiple points.
At these sites, electrons could be transferred through the outer membranes of the bacteria to the conductive network of graphene nano-ribbons – the electrical wires, so to speak. A current of about 65 nanoamperes is generated. Although this current is insufficient to power an electronic device, the researchers say that a wide variety of bionic fungi could generate enough current to light an LED bulb. The researchers are now working on ways to generate higher currents using this system.
____________________________
CDC CANNOT MAKE LAWS
(X22) While Congress Is Away- The Month Of August Is Traditionally A Really Hot Month: Gov Desantis wins in Court vs CDC re Cruise Ships! CDC cannot create laws!
____________________________
WHO’S WHO
Chinese Military Discussed Weaponizing COVID In 2015 ‘To Cause Enemy’s Medical System To Collapse’_Article
The study also examines the optimum conditions under which to release a bioweapon. “Bioweapon attacks are best conducted during dawn, dusk, night or cloudy weather because intense sunlight can damage the pathogens,” it states. “Biological agents should be released during dry weather. Rain or snow can cause the aerosol particles to precipitate.
“A stable wind direction is desirable so that the aerosol can float into the target area.”
____________________________
Kamala Harris Tells Activists to Knock on Doors and Harass People Who Haven’t Been Vaccinated in Desperate Push to Meet 4th of July Goal (VIDEO)
EXCERPT:
Have young children? Kamala’s got you covered.
“Other folks who need time to recover after they get the shot, right? And may need a little moment where they need some help with their kids. So we have partnered with the YMCA, with KinderCare, and the Learning Care Group to provide free childcare for both vaccination and recovery. We need to meet people where they are.”
____________________________
TRACKING:
Vaccinated people are being TRACKED in real time!!! – https://tapnewswire.com/2021/06/vaccinated-people-are-being-tracked-in-real-time/
____________________________
LEGAL MATTERS:
AAPS says COVID Shot Home Visits Unconstitutional and Unethical
The Biden Administration has announced plans to send agents “door to door” in order to “get remaining Americans vaccinated, by ensuring they have the information they need on how both safe and accessible the vaccine is.”
A leaked script from the Lake County Health Department in Illinois tells the Community Health Ambassadors to keep track of the addresses and responses from residents in a “Doorknocking Spreadsheet.”
The Association of American Physicians and Surgeons (AAPS) makes the following observations:
— The U.S. Constitution provides no authority for the federal government to be involved in medicine, for example, by recommending, promoting, or mandating treatments.
— If the Ambassador knows a person’s vaccination status, the government has already been collecting personal health data and sharing it with agents having nothing to do with the person’s care, a violation of the Fourth Amendment. The Health Insurance Portability and Accountability Act (HIPAA) will not protect you—it allows very broad disclosure to government officials.
— States have the lawful authority to regulate the practice of medicine, but the Ambassadors are evidently not under any constraints regarding training, credentialing, documentation, or scope of practice, although they are collecting data and giving medical advice without supervision. Even medical assistants and medical scribes need to meet certain qualifications.
— Ambassadors are promoting an experimental product, with no information on risks. Even if a product is FDA-approved, advertisers and medical professionals must divulge risks, such as heart inflammation, paralysis from Guillain-Barré or other causes, miscarriage, or death. Contrast the Ambassador’s script with the disclosures on a television ad for a drug, say one to treat your dog’s heartworm.
In the opinion of AAPS, this door-to-door solicitation violates the ethical principles of protecting confidentiality and informed consent. Health professionals need a patient’s implied consent even to be seen; they may not simply show up uninvited at a stranger’s home.
For both legal and ethical reasons, the program should be discontinued at once, AAPS states.
The Association of American Physicians and Surgeons has represented physicians in all specialties since 1943. Its motto is omnia pro aegroto, everything for the patient.
====================================
US Military Confirms Heart Inflammation After COVID Vaccine
====================================
Before vs. After Vaccine Blood Work Shows Troubling Indicators: Inflammation? Carcinogens?
====================================
Del Bigtree’s ‘The Highwire’ — Episode 224: THE COVID CARTEL
The $1 Billion Whistleblower Search; International Vaccine Mandates Start; W.H.O. Insider Exposes Pandemic Response; The Ultimate Proof Masks Don’t Work!
Excellent show today. Del Bigtree had a WHO whistleblower on – very important information.
Guest: Astrid Stuckelberger, PhD
______________________________________
https://www.rumormillnews.com/cgi-bin/forum.cgi?read=176958
AUTOPSY:
ncbi.nlm.nih.gov/pmc/articles/PMC8051011/
___________________
ACTUAL FAUX_VAX PANDEMIC:
IRISH GOVT ADMITS CV DOESN’T EXIST (April 2021):
PETER MCCOLLOUGH MD: ALREADY 50,000 AMERICANS KILLED BY INJECTIONS:
Dr. Peter McCullough: ‘whistleblowers’ inside CDC claim injections have already killed 50,000 Americans
ISRAEL & AUTRALIA – ALL COVID PATIENTS ARE “VAXXED”:
TWO OUT OF THREE ADMITTED IS VAXXED IN ICELAND:
https://www.ruv.is/frett/2021/08/06/tvo-af-hverjum-thremur-sem-hafa-lagst-inn-eru-bolusett
DR. KOBI HAVIV: 95% OF SEVERE PATIENTS ARE INJECTED:
German Chief Pathologist:
Over 500,000 FAUX-VAX DEATHS: ATTY. THOMAS RENZ (See it on Brighteon.)
Atty Thomas Renz- half-million+ faux-vax deaths 2021.8.6 f0ead934c708b11f
Freedom Fighter in Alberta, Canada:
Johns Hopkins Dr Says, “IGNORE CDC GUIDANCE!”
Legal violations of Gain-of-Function Research
youtube.com/watch?v=3GzzBD1kJ0g
A Pathologist’s Summary of Harm:
100% OF PASSENGERS ON CRUISE ARE INJECTED BUT ILL
Loss of immunity over time following injections:
Dr. David Bauer.
https://gab.com/stirling/posts/106723403742186796
80% of Pregnant Women will miscarry:
Prof Sucharit Bhakdi – “The Covid gene injection will decimate world population.”
Driven by False-Positive “Tests”: Dr. Michael Yeadon.
_________________________________
NO CONTROL GROUP FOR THE GRAND EXPERIMENT!
_________________________________
LAWSUITS:
$500 TRILLION LAWSUIT:
Lawyer Nikos Antoniades announces massive 4311-page lawsuit re covid & the injection
Fake Ancient Alien Theorist Foolishly Visits the Collective Imagination 